COX 2-selective NSAIDs: Biology, promises, and concerns

Article Type
Changed
Mon, 03/11/2019 - 08:31
Display Headline
COX 2-selective NSAIDs: Biology, promises, and concerns
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Education program director, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has received personal honoraria, support for educational programs, or research support from Amgen, Ciba-Geigy (Novartis), Merck, Searle, Smith Kline Beecham, and Wyeth Pharmaceuticals.

Issue
Cleveland Clinic Journal of Medicine - 66(5)
Publications
Page Number
285-286, 288-292
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Education program director, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has received personal honoraria, support for educational programs, or research support from Amgen, Ciba-Geigy (Novartis), Merck, Searle, Smith Kline Beecham, and Wyeth Pharmaceuticals.

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Education program director, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has received personal honoraria, support for educational programs, or research support from Amgen, Ciba-Geigy (Novartis), Merck, Searle, Smith Kline Beecham, and Wyeth Pharmaceuticals.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 66(5)
Issue
Cleveland Clinic Journal of Medicine - 66(5)
Page Number
285-286, 288-292
Page Number
285-286, 288-292
Publications
Publications
Article Type
Display Headline
COX 2-selective NSAIDs: Biology, promises, and concerns
Display Headline
COX 2-selective NSAIDs: Biology, promises, and concerns
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media